NeuroControl Vocare Reduces Urinary Tract Infection By 78%, Receives HDE
This article was originally published in The Gray Sheet
Executive Summary
Use of NeuroControl's Vocare bladder control system reduced urinary tract infections after surgery by 78% in 23 patients involved in the firm's ongoing U.S. trial.
You may also be interested in...
Rochester Medical FemSoft Incontinence Insert Among FY 1999's 33 PMAs
FDA approval of Rochester Medical's FemSoft insert for female stress urinary incontinence on Sept. 30, the final day of the federal government's fiscal year, apparently put the agency's total number of approved, original premarket approval applications for the year at 33, down from 42 in 1998 and 46 in 1997.
QUOTED. 6 May 2020. Paul Diaz.
Myriad has sold several business units as it narrows its focus to oncology, women's health and mental health diagnostics. CEO Paul Diaz says the moves will allow the company to be a market leader.